nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Clenbuterol—TNF—hematologic cancer	0.00265	0.413	CrCbGaD
Pirbuterol—Epinephrine—SLC22A1—hematologic cancer	0.00154	0.241	CrCbGaD
Pirbuterol—Epinephrine—TNF—hematologic cancer	0.00111	0.173	CrCbGaD
Pirbuterol—Nadolol—ABCB1—hematologic cancer	0.00111	0.173	CrCbGaD
Pirbuterol—Anxiety—Betamethasone—hematologic cancer	0.000321	0.000356	CcSEcCtD
Pirbuterol—Anxiety—Dexamethasone—hematologic cancer	0.000321	0.000356	CcSEcCtD
Pirbuterol—Dizziness—Carmustine—hematologic cancer	0.000321	0.000356	CcSEcCtD
Pirbuterol—Rash—Thalidomide—hematologic cancer	0.000319	0.000353	CcSEcCtD
Pirbuterol—Dermatitis—Thalidomide—hematologic cancer	0.000318	0.000353	CcSEcCtD
Pirbuterol—Dizziness—Alitretinoin—hematologic cancer	0.000318	0.000352	CcSEcCtD
Pirbuterol—Diarrhoea—Vincristine—hematologic cancer	0.000317	0.000351	CcSEcCtD
Pirbuterol—Headache—Thalidomide—hematologic cancer	0.000317	0.000351	CcSEcCtD
Pirbuterol—Asthenia—Gemcitabine—hematologic cancer	0.000315	0.000349	CcSEcCtD
Pirbuterol—Dizziness—Ifosfamide—hematologic cancer	0.000314	0.000348	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—hematologic cancer	0.000312	0.000345	CcSEcCtD
Pirbuterol—Pruritus—Gemcitabine—hematologic cancer	0.000311	0.000345	CcSEcCtD
Pirbuterol—Nausea—Thiotepa—hematologic cancer	0.00031	0.000344	CcSEcCtD
Pirbuterol—Feeling abnormal—Etoposide—hematologic cancer	0.000309	0.000343	CcSEcCtD
Pirbuterol—Oedema—Betamethasone—hematologic cancer	0.000309	0.000342	CcSEcCtD
Pirbuterol—Oedema—Dexamethasone—hematologic cancer	0.000309	0.000342	CcSEcCtD
Pirbuterol—Diarrhoea—Mitoxantrone—hematologic cancer	0.000309	0.000342	CcSEcCtD
Pirbuterol—Diarrhoea—Irinotecan—hematologic cancer	0.000309	0.000342	CcSEcCtD
Pirbuterol—Vomiting—Carmustine—hematologic cancer	0.000309	0.000342	CcSEcCtD
Pirbuterol—Insomnia—Triamcinolone—hematologic cancer	0.000308	0.000341	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Etoposide—hematologic cancer	0.000307	0.00034	CcSEcCtD
Pirbuterol—Dizziness—Vincristine—hematologic cancer	0.000306	0.00034	CcSEcCtD
Pirbuterol—Rash—Carmustine—hematologic cancer	0.000306	0.000339	CcSEcCtD
Pirbuterol—Dermatitis—Carmustine—hematologic cancer	0.000306	0.000339	CcSEcCtD
Pirbuterol—Vomiting—Alitretinoin—hematologic cancer	0.000306	0.000339	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—hematologic cancer	0.000305	0.000338	CcSEcCtD
Pirbuterol—Feeling abnormal—Prednisolone—hematologic cancer	0.000305	0.000338	CcSEcCtD
Pirbuterol—Headache—Carmustine—hematologic cancer	0.000304	0.000337	CcSEcCtD
Pirbuterol—Shock—Betamethasone—hematologic cancer	0.000304	0.000337	CcSEcCtD
Pirbuterol—Shock—Dexamethasone—hematologic cancer	0.000304	0.000337	CcSEcCtD
Pirbuterol—Rash—Alitretinoin—hematologic cancer	0.000303	0.000336	CcSEcCtD
Pirbuterol—Agitation—Prednisone—hematologic cancer	0.000303	0.000336	CcSEcCtD
Pirbuterol—Dermatitis—Alitretinoin—hematologic cancer	0.000303	0.000336	CcSEcCtD
Pirbuterol—Vomiting—Ifosfamide—hematologic cancer	0.000302	0.000335	CcSEcCtD
Pirbuterol—Tachycardia—Dexamethasone—hematologic cancer	0.000301	0.000334	CcSEcCtD
Pirbuterol—Tachycardia—Betamethasone—hematologic cancer	0.000301	0.000334	CcSEcCtD
Pirbuterol—Headache—Alitretinoin—hematologic cancer	0.000301	0.000334	CcSEcCtD
Pirbuterol—Diarrhoea—Gemcitabine—hematologic cancer	0.000301	0.000333	CcSEcCtD
Pirbuterol—Nausea—Thalidomide—hematologic cancer	0.0003	0.000333	CcSEcCtD
Pirbuterol—Rash—Ifosfamide—hematologic cancer	0.0003	0.000332	CcSEcCtD
Pirbuterol—Dermatitis—Ifosfamide—hematologic cancer	0.000299	0.000332	CcSEcCtD
Pirbuterol—Dizziness—Irinotecan—hematologic cancer	0.000298	0.000331	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—hematologic cancer	0.000297	0.00033	CcSEcCtD
Pirbuterol—Abdominal pain—Etoposide—hematologic cancer	0.000297	0.000329	CcSEcCtD
Pirbuterol—Syncope—Prednisone—hematologic cancer	0.000296	0.000328	CcSEcCtD
Pirbuterol—Hypoaesthesia—Epirubicin—hematologic cancer	0.000295	0.000327	CcSEcCtD
Pirbuterol—Vomiting—Vincristine—hematologic cancer	0.000295	0.000326	CcSEcCtD
Pirbuterol—Anorexia—Dexamethasone—hematologic cancer	0.000294	0.000326	CcSEcCtD
Pirbuterol—Anorexia—Betamethasone—hematologic cancer	0.000294	0.000326	CcSEcCtD
Pirbuterol—Asthenia—Cisplatin—hematologic cancer	0.000294	0.000326	CcSEcCtD
Pirbuterol—Fatigue—Triamcinolone—hematologic cancer	0.000293	0.000325	CcSEcCtD
Pirbuterol—Rash—Vincristine—hematologic cancer	0.000292	0.000324	CcSEcCtD
Pirbuterol—Dermatitis—Vincristine—hematologic cancer	0.000292	0.000323	CcSEcCtD
Pirbuterol—Headache—Vincristine—hematologic cancer	0.00029	0.000322	CcSEcCtD
Pirbuterol—Loss of consciousness—Prednisone—hematologic cancer	0.00029	0.000321	CcSEcCtD
Pirbuterol—Hypotension—Betamethasone—hematologic cancer	0.000289	0.00032	CcSEcCtD
Pirbuterol—Hypotension—Dexamethasone—hematologic cancer	0.000289	0.00032	CcSEcCtD
Pirbuterol—Nausea—Carmustine—hematologic cancer	0.000288	0.000319	CcSEcCtD
Pirbuterol—Vomiting—Irinotecan—hematologic cancer	0.000287	0.000318	CcSEcCtD
Pirbuterol—Vomiting—Mitoxantrone—hematologic cancer	0.000287	0.000318	CcSEcCtD
Pirbuterol—Nausea—Alitretinoin—hematologic cancer	0.000286	0.000317	CcSEcCtD
Pirbuterol—Rash—Irinotecan—hematologic cancer	0.000284	0.000315	CcSEcCtD
Pirbuterol—Rash—Mitoxantrone—hematologic cancer	0.000284	0.000315	CcSEcCtD
Pirbuterol—Dermatitis—Mitoxantrone—hematologic cancer	0.000284	0.000315	CcSEcCtD
Pirbuterol—Dermatitis—Irinotecan—hematologic cancer	0.000284	0.000315	CcSEcCtD
Pirbuterol—Headache—Mitoxantrone—hematologic cancer	0.000283	0.000313	CcSEcCtD
Pirbuterol—Headache—Irinotecan—hematologic cancer	0.000283	0.000313	CcSEcCtD
Pirbuterol—Nausea—Ifosfamide—hematologic cancer	0.000282	0.000313	CcSEcCtD
Pirbuterol—Feeling abnormal—Triamcinolone—hematologic cancer	0.000281	0.000311	CcSEcCtD
Pirbuterol—Diarrhoea—Cisplatin—hematologic cancer	0.00028	0.000311	CcSEcCtD
Pirbuterol—Anxiety—Prednisone—hematologic cancer	0.00028	0.00031	CcSEcCtD
Pirbuterol—Alopecia—Methotrexate—hematologic cancer	0.00028	0.00031	CcSEcCtD
Pirbuterol—Vomiting—Gemcitabine—hematologic cancer	0.000279	0.00031	CcSEcCtD
Pirbuterol—Insomnia—Dexamethasone—hematologic cancer	0.000279	0.00031	CcSEcCtD
Pirbuterol—Insomnia—Betamethasone—hematologic cancer	0.000279	0.00031	CcSEcCtD
Pirbuterol—Rash—Gemcitabine—hematologic cancer	0.000277	0.000307	CcSEcCtD
Pirbuterol—Dermatitis—Gemcitabine—hematologic cancer	0.000277	0.000307	CcSEcCtD
Pirbuterol—Headache—Gemcitabine—hematologic cancer	0.000275	0.000305	CcSEcCtD
Pirbuterol—Nausea—Vincristine—hematologic cancer	0.000275	0.000305	CcSEcCtD
Pirbuterol—Flushing—Epirubicin—hematologic cancer	0.000275	0.000305	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000273	0.000302	CcSEcCtD
Pirbuterol—Asthenia—Etoposide—hematologic cancer	0.000269	0.000298	CcSEcCtD
Pirbuterol—Oedema—Prednisone—hematologic cancer	0.000269	0.000298	CcSEcCtD
Pirbuterol—Decreased appetite—Dexamethasone—hematologic cancer	0.000268	0.000298	CcSEcCtD
Pirbuterol—Decreased appetite—Betamethasone—hematologic cancer	0.000268	0.000298	CcSEcCtD
Pirbuterol—Nausea—Mitoxantrone—hematologic cancer	0.000268	0.000297	CcSEcCtD
Pirbuterol—Nausea—Irinotecan—hematologic cancer	0.000268	0.000297	CcSEcCtD
Pirbuterol—Back pain—Methotrexate—hematologic cancer	0.000266	0.000295	CcSEcCtD
Pirbuterol—Fatigue—Dexamethasone—hematologic cancer	0.000266	0.000295	CcSEcCtD
Pirbuterol—Fatigue—Betamethasone—hematologic cancer	0.000266	0.000295	CcSEcCtD
Pirbuterol—Pruritus—Etoposide—hematologic cancer	0.000266	0.000294	CcSEcCtD
Pirbuterol—Shock—Prednisone—hematologic cancer	0.000265	0.000293	CcSEcCtD
Pirbuterol—Tachycardia—Prednisone—hematologic cancer	0.000263	0.000291	CcSEcCtD
Pirbuterol—Alopecia—Epirubicin—hematologic cancer	0.000262	0.00029	CcSEcCtD
Pirbuterol—Nausea—Gemcitabine—hematologic cancer	0.000261	0.000289	CcSEcCtD
Pirbuterol—Vomiting—Cisplatin—hematologic cancer	0.00026	0.000289	CcSEcCtD
Pirbuterol—Rash—Cisplatin—hematologic cancer	0.000258	0.000286	CcSEcCtD
Pirbuterol—Dermatitis—Cisplatin—hematologic cancer	0.000258	0.000286	CcSEcCtD
Pirbuterol—Diarrhoea—Etoposide—hematologic cancer	0.000257	0.000285	CcSEcCtD
Pirbuterol—Anorexia—Prednisone—hematologic cancer	0.000256	0.000284	CcSEcCtD
Pirbuterol—Feeling abnormal—Betamethasone—hematologic cancer	0.000255	0.000282	CcSEcCtD
Pirbuterol—Feeling abnormal—Dexamethasone—hematologic cancer	0.000255	0.000282	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—hematologic cancer	0.000254	0.000282	CcSEcCtD
Pirbuterol—Tension—Epirubicin—hematologic cancer	0.000253	0.00028	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000253	0.00028	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000253	0.00028	CcSEcCtD
Pirbuterol—Nervousness—Epirubicin—hematologic cancer	0.00025	0.000277	CcSEcCtD
Pirbuterol—Back pain—Epirubicin—hematologic cancer	0.000249	0.000276	CcSEcCtD
Pirbuterol—Dizziness—Etoposide—hematologic cancer	0.000248	0.000275	CcSEcCtD
Pirbuterol—Muscle spasms—Epirubicin—hematologic cancer	0.000248	0.000275	CcSEcCtD
Pirbuterol—Dizziness—Prednisolone—hematologic cancer	0.000245	0.000271	CcSEcCtD
Pirbuterol—Asthenia—Triamcinolone—hematologic cancer	0.000244	0.000271	CcSEcCtD
Pirbuterol—Abdominal pain—Betamethasone—hematologic cancer	0.000244	0.000271	CcSEcCtD
Pirbuterol—Abdominal pain—Dexamethasone—hematologic cancer	0.000244	0.000271	CcSEcCtD
Pirbuterol—Nausea—Cisplatin—hematologic cancer	0.000243	0.00027	CcSEcCtD
Pirbuterol—Insomnia—Prednisone—hematologic cancer	0.000243	0.00027	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—hematologic cancer	0.000242	0.000268	CcSEcCtD
Pirbuterol—Pruritus—Triamcinolone—hematologic cancer	0.000241	0.000267	CcSEcCtD
Pirbuterol—Cough—Methotrexate—hematologic cancer	0.00024	0.000266	CcSEcCtD
Pirbuterol—Vomiting—Etoposide—hematologic cancer	0.000239	0.000264	CcSEcCtD
Pirbuterol—Agitation—Epirubicin—hematologic cancer	0.000237	0.000263	CcSEcCtD
Pirbuterol—Rash—Etoposide—hematologic cancer	0.000237	0.000262	CcSEcCtD
Pirbuterol—Dermatitis—Etoposide—hematologic cancer	0.000236	0.000262	CcSEcCtD
Pirbuterol—Headache—Etoposide—hematologic cancer	0.000235	0.000261	CcSEcCtD
Pirbuterol—Chest pain—Methotrexate—hematologic cancer	0.000234	0.00026	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—hematologic cancer	0.000234	0.000259	CcSEcCtD
Pirbuterol—Decreased appetite—Prednisone—hematologic cancer	0.000234	0.000259	CcSEcCtD
Pirbuterol—Rash—Prednisolone—hematologic cancer	0.000233	0.000259	CcSEcCtD
Pirbuterol—Dermatitis—Prednisolone—hematologic cancer	0.000233	0.000258	CcSEcCtD
Pirbuterol—Fatigue—Prednisone—hematologic cancer	0.000232	0.000257	CcSEcCtD
Pirbuterol—Headache—Prednisolone—hematologic cancer	0.000232	0.000257	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—hematologic cancer	0.000232	0.000257	CcSEcCtD
Pirbuterol—Syncope—Epirubicin—hematologic cancer	0.000231	0.000256	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—hematologic cancer	0.000231	0.000256	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—hematologic cancer	0.000229	0.000254	CcSEcCtD
Pirbuterol—Palpitations—Epirubicin—hematologic cancer	0.000228	0.000252	CcSEcCtD
Pirbuterol—Confusional state—Methotrexate—hematologic cancer	0.000227	0.000251	CcSEcCtD
Pirbuterol—Loss of consciousness—Epirubicin—hematologic cancer	0.000227	0.000251	CcSEcCtD
Pirbuterol—Dizziness—Triamcinolone—hematologic cancer	0.000225	0.000249	CcSEcCtD
Pirbuterol—Cough—Epirubicin—hematologic cancer	0.000225	0.000249	CcSEcCtD
Pirbuterol—Nausea—Etoposide—hematologic cancer	0.000223	0.000247	CcSEcCtD
Pirbuterol—Feeling abnormal—Prednisone—hematologic cancer	0.000222	0.000246	CcSEcCtD
Pirbuterol—Asthenia—Betamethasone—hematologic cancer	0.000222	0.000246	CcSEcCtD
Pirbuterol—Asthenia—Dexamethasone—hematologic cancer	0.000222	0.000246	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Prednisone—hematologic cancer	0.00022	0.000244	CcSEcCtD
Pirbuterol—Nausea—Prednisolone—hematologic cancer	0.00022	0.000244	CcSEcCtD
Pirbuterol—Chest pain—Epirubicin—hematologic cancer	0.000219	0.000243	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—hematologic cancer	0.000219	0.000243	CcSEcCtD
Pirbuterol—Anxiety—Epirubicin—hematologic cancer	0.000219	0.000242	CcSEcCtD
Pirbuterol—Pruritus—Betamethasone—hematologic cancer	0.000219	0.000242	CcSEcCtD
Pirbuterol—Pruritus—Dexamethasone—hematologic cancer	0.000219	0.000242	CcSEcCtD
Pirbuterol—Vomiting—Triamcinolone—hematologic cancer	0.000216	0.00024	CcSEcCtD
Pirbuterol—Rash—Triamcinolone—hematologic cancer	0.000215	0.000238	CcSEcCtD
Pirbuterol—Dry mouth—Epirubicin—hematologic cancer	0.000215	0.000238	CcSEcCtD
Pirbuterol—Dermatitis—Triamcinolone—hematologic cancer	0.000214	0.000238	CcSEcCtD
Pirbuterol—Anorexia—Methotrexate—hematologic cancer	0.000214	0.000237	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—hematologic cancer	0.000214	0.000237	CcSEcCtD
Pirbuterol—Headache—Triamcinolone—hematologic cancer	0.000213	0.000236	CcSEcCtD
Pirbuterol—Abdominal pain—Prednisone—hematologic cancer	0.000213	0.000236	CcSEcCtD
Pirbuterol—Confusional state—Epirubicin—hematologic cancer	0.000212	0.000235	CcSEcCtD
Pirbuterol—Diarrhoea—Dexamethasone—hematologic cancer	0.000211	0.000234	CcSEcCtD
Pirbuterol—Diarrhoea—Betamethasone—hematologic cancer	0.000211	0.000234	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—hematologic cancer	0.000211	0.000234	CcSEcCtD
Pirbuterol—Oedema—Epirubicin—hematologic cancer	0.00021	0.000233	CcSEcCtD
Pirbuterol—Hypotension—Methotrexate—hematologic cancer	0.00021	0.000233	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—hematologic cancer	0.00021	0.000232	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—hematologic cancer	0.000208	0.000231	CcSEcCtD
Pirbuterol—Shock—Epirubicin—hematologic cancer	0.000207	0.000229	CcSEcCtD
Pirbuterol—Tachycardia—Epirubicin—hematologic cancer	0.000205	0.000228	CcSEcCtD
Pirbuterol—Dizziness—Dexamethasone—hematologic cancer	0.000204	0.000226	CcSEcCtD
Pirbuterol—Dizziness—Betamethasone—hematologic cancer	0.000204	0.000226	CcSEcCtD
Pirbuterol—Insomnia—Methotrexate—hematologic cancer	0.000203	0.000225	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—hematologic cancer	0.000203	0.000225	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—hematologic cancer	0.000202	0.000224	CcSEcCtD
Pirbuterol—Nausea—Triamcinolone—hematologic cancer	0.000202	0.000224	CcSEcCtD
Pirbuterol—Anorexia—Epirubicin—hematologic cancer	0.000201	0.000222	CcSEcCtD
Pirbuterol—Somnolence—Methotrexate—hematologic cancer	0.0002	0.000221	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—hematologic cancer	0.000199	0.00022	CcSEcCtD
Pirbuterol—Hypotension—Epirubicin—hematologic cancer	0.000197	0.000218	CcSEcCtD
Pirbuterol—Vomiting—Betamethasone—hematologic cancer	0.000196	0.000218	CcSEcCtD
Pirbuterol—Vomiting—Dexamethasone—hematologic cancer	0.000196	0.000218	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—hematologic cancer	0.000196	0.000218	CcSEcCtD
Pirbuterol—Decreased appetite—Methotrexate—hematologic cancer	0.000195	0.000217	CcSEcCtD
Pirbuterol—Rash—Betamethasone—hematologic cancer	0.000195	0.000216	CcSEcCtD
Pirbuterol—Rash—Dexamethasone—hematologic cancer	0.000195	0.000216	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—hematologic cancer	0.000195	0.000216	CcSEcCtD
Pirbuterol—Dermatitis—Dexamethasone—hematologic cancer	0.000195	0.000216	CcSEcCtD
Pirbuterol—Dermatitis—Betamethasone—hematologic cancer	0.000195	0.000216	CcSEcCtD
Pirbuterol—Fatigue—Methotrexate—hematologic cancer	0.000194	0.000215	CcSEcCtD
Pirbuterol—Headache—Betamethasone—hematologic cancer	0.000193	0.000214	CcSEcCtD
Pirbuterol—Headache—Dexamethasone—hematologic cancer	0.000193	0.000214	CcSEcCtD
Pirbuterol—Asthenia—Prednisone—hematologic cancer	0.000193	0.000214	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—hematologic cancer	0.000192	0.000212	CcSEcCtD
Pirbuterol—Pruritus—Prednisone—hematologic cancer	0.00019	0.000211	CcSEcCtD
Pirbuterol—Insomnia—Epirubicin—hematologic cancer	0.00019	0.000211	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—hematologic cancer	0.00019	0.000211	CcSEcCtD
Pirbuterol—Somnolence—Epirubicin—hematologic cancer	0.000187	0.000207	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—hematologic cancer	0.000186	0.000206	CcSEcCtD
Pirbuterol—Feeling abnormal—Methotrexate—hematologic cancer	0.000185	0.000205	CcSEcCtD
Pirbuterol—Diarrhoea—Prednisone—hematologic cancer	0.000184	0.000204	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000184	0.000204	CcSEcCtD
Pirbuterol—Nausea—Dexamethasone—hematologic cancer	0.000183	0.000203	CcSEcCtD
Pirbuterol—Nausea—Betamethasone—hematologic cancer	0.000183	0.000203	CcSEcCtD
Pirbuterol—Decreased appetite—Epirubicin—hematologic cancer	0.000183	0.000203	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—hematologic cancer	0.000182	0.000202	CcSEcCtD
Pirbuterol—Fatigue—Epirubicin—hematologic cancer	0.000181	0.000201	CcSEcCtD
Pirbuterol—Dizziness—Prednisone—hematologic cancer	0.000178	0.000197	CcSEcCtD
Pirbuterol—Abdominal pain—Methotrexate—hematologic cancer	0.000178	0.000197	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—hematologic cancer	0.000176	0.000195	CcSEcCtD
Pirbuterol—Feeling abnormal—Epirubicin—hematologic cancer	0.000173	0.000192	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—hematologic cancer	0.000173	0.000192	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000172	0.000191	CcSEcCtD
Pirbuterol—Vomiting—Prednisone—hematologic cancer	0.000171	0.00019	CcSEcCtD
Pirbuterol—Rash—Prednisone—hematologic cancer	0.00017	0.000188	CcSEcCtD
Pirbuterol—Dermatitis—Prednisone—hematologic cancer	0.000169	0.000188	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—hematologic cancer	0.000169	0.000188	CcSEcCtD
Pirbuterol—Headache—Prednisone—hematologic cancer	0.000169	0.000187	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—hematologic cancer	0.000168	0.000186	CcSEcCtD
Pirbuterol—Abdominal pain—Epirubicin—hematologic cancer	0.000166	0.000184	CcSEcCtD
Pirbuterol—Asthenia—Methotrexate—hematologic cancer	0.000161	0.000179	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—hematologic cancer	0.00016	0.000178	CcSEcCtD
Pirbuterol—Nausea—Prednisone—hematologic cancer	0.00016	0.000177	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000159	0.000176	CcSEcCtD
Pirbuterol—Pruritus—Methotrexate—hematologic cancer	0.000159	0.000176	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—hematologic cancer	0.000154	0.000171	CcSEcCtD
Pirbuterol—Diarrhoea—Methotrexate—hematologic cancer	0.000154	0.00017	CcSEcCtD
Pirbuterol—Asthenia—Epirubicin—hematologic cancer	0.000151	0.000167	CcSEcCtD
Pirbuterol—Pruritus—Epirubicin—hematologic cancer	0.000149	0.000165	CcSEcCtD
Pirbuterol—Dizziness—Methotrexate—hematologic cancer	0.000149	0.000165	CcSEcCtD
Pirbuterol—Diarrhoea—Epirubicin—hematologic cancer	0.000144	0.00016	CcSEcCtD
Pirbuterol—Vomiting—Methotrexate—hematologic cancer	0.000143	0.000158	CcSEcCtD
Pirbuterol—Rash—Methotrexate—hematologic cancer	0.000142	0.000157	CcSEcCtD
Pirbuterol—Dermatitis—Methotrexate—hematologic cancer	0.000142	0.000157	CcSEcCtD
Pirbuterol—Headache—Methotrexate—hematologic cancer	0.000141	0.000156	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—hematologic cancer	0.00014	0.000155	CcSEcCtD
Pirbuterol—Dizziness—Epirubicin—hematologic cancer	0.000139	0.000154	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—hematologic cancer	0.000138	0.000153	CcSEcCtD
Pirbuterol—Vomiting—Epirubicin—hematologic cancer	0.000134	0.000148	CcSEcCtD
Pirbuterol—Nausea—Methotrexate—hematologic cancer	0.000134	0.000148	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—hematologic cancer	0.000133	0.000148	CcSEcCtD
Pirbuterol—Rash—Epirubicin—hematologic cancer	0.000133	0.000147	CcSEcCtD
Pirbuterol—Dermatitis—Epirubicin—hematologic cancer	0.000133	0.000147	CcSEcCtD
Pirbuterol—Headache—Epirubicin—hematologic cancer	0.000132	0.000146	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—hematologic cancer	0.000129	0.000143	CcSEcCtD
Pirbuterol—Nausea—Epirubicin—hematologic cancer	0.000125	0.000138	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—hematologic cancer	0.000124	0.000137	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—hematologic cancer	0.000123	0.000136	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—hematologic cancer	0.000123	0.000136	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—hematologic cancer	0.000122	0.000135	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—hematologic cancer	0.000116	0.000128	CcSEcCtD
Pirbuterol—ADRB1—Signaling Pathways—STAT5B—hematologic cancer	5.66e-05	0.00062	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—JAK1—hematologic cancer	5.64e-05	0.000617	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCG—hematologic cancer	5.64e-05	0.000617	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RAC2—hematologic cancer	5.63e-05	0.000616	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—DKK1—hematologic cancer	5.58e-05	0.000611	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT5B—hematologic cancer	5.54e-05	0.000606	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADCY7—hematologic cancer	5.5e-05	0.000602	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CSF2—hematologic cancer	5.42e-05	0.000594	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—IL2RA—hematologic cancer	5.38e-05	0.000589	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ADCY7—hematologic cancer	5.38e-05	0.000589	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—XIAP—hematologic cancer	5.35e-05	0.000585	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CSF2—hematologic cancer	5.3e-05	0.000581	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—IL2RA—hematologic cancer	5.26e-05	0.000577	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—JAK1—hematologic cancer	5.23e-05	0.000573	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCG—hematologic cancer	5.23e-05	0.000573	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—XIAP—hematologic cancer	5.23e-05	0.000573	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SH2B3—hematologic cancer	5.21e-05	0.000571	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SMARCA4—hematologic cancer	5.21e-05	0.000571	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GZMB—hematologic cancer	5.18e-05	0.000567	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCG—hematologic cancer	5.12e-05	0.000561	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—JAK1—hematologic cancer	5.12e-05	0.000561	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SMARCA4—hematologic cancer	5.1e-05	0.000558	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SH2B3—hematologic cancer	5.1e-05	0.000558	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GZMB—hematologic cancer	5.06e-05	0.000555	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CTNNA1—hematologic cancer	5.06e-05	0.000554	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EIF4EBP1—hematologic cancer	5.03e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL3—hematologic cancer	5.03e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HSPB1—hematologic cancer	5.03e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTHLH—hematologic cancer	4.97e-05	0.000544	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SDC1—hematologic cancer	4.97e-05	0.000544	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CTNNA1—hematologic cancer	4.95e-05	0.000542	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HSPB1—hematologic cancer	4.92e-05	0.000538	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EIF4EBP1—hematologic cancer	4.92e-05	0.000538	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL3—hematologic cancer	4.92e-05	0.000538	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL2RA—hematologic cancer	4.89e-05	0.000535	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTHLH—hematologic cancer	4.86e-05	0.000532	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SDC1—hematologic cancer	4.86e-05	0.000532	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTGER4—hematologic cancer	4.84e-05	0.00053	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LCK—hematologic cancer	4.81e-05	0.000527	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL2RA—hematologic cancer	4.78e-05	0.000524	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTGER4—hematologic cancer	4.73e-05	0.000518	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—H3F3A—hematologic cancer	4.72e-05	0.000517	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LCK—hematologic cancer	4.71e-05	0.000516	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	4.62e-05	0.000505	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCZ—hematologic cancer	4.59e-05	0.000502	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	4.49e-05	0.000491	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—hematologic cancer	4.48e-05	0.000491	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PARP1—hematologic cancer	4.43e-05	0.000485	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	4.39e-05	0.00048	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FBXW7—hematologic cancer	4.36e-05	0.000477	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PARP1—hematologic cancer	4.33e-05	0.000475	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HDAC2—hematologic cancer	4.27e-05	0.000468	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	4.27e-05	0.000468	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	4.26e-05	0.000467	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	4.18e-05	0.000458	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	4.18e-05	0.000458	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CBL—hematologic cancer	4.16e-05	0.000456	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL3—hematologic cancer	4.12e-05	0.000451	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CBL—hematologic cancer	4.07e-05	0.000446	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	4.07e-05	0.000446	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	4.05e-05	0.000444	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL3—hematologic cancer	4.03e-05	0.000441	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	4e-05	0.000438	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	3.99e-05	0.000437	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	3.98e-05	0.000436	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	3.97e-05	0.000435	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SYK—hematologic cancer	3.97e-05	0.000435	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	3.96e-05	0.000434	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	3.94e-05	0.000432	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	3.91e-05	0.000428	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	3.9e-05	0.000427	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SYK—hematologic cancer	3.89e-05	0.000426	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	3.89e-05	0.000426	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	3.88e-05	0.000424	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	3.86e-05	0.000422	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	3.83e-05	0.00042	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	3.79e-05	0.000415	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	3.79e-05	0.000415	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	3.78e-05	0.000414	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	3.75e-05	0.00041	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.72e-05	0.000408	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	3.71e-05	0.000406	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	3.7e-05	0.000405	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	3.64e-05	0.000399	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	3.62e-05	0.000396	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	3.6e-05	0.000395	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	3.58e-05	0.000393	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	3.58e-05	0.000392	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	3.58e-05	0.000392	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	3.54e-05	0.000387	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	3.52e-05	0.000386	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	3.52e-05	0.000386	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	3.51e-05	0.000384	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	3.5e-05	0.000383	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	3.5e-05	0.000383	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	3.45e-05	0.000378	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	3.44e-05	0.000377	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.44e-05	0.000376	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	3.41e-05	0.000374	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	3.38e-05	0.00037	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	3.37e-05	0.000369	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	3.36e-05	0.000368	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	3.34e-05	0.000366	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	3.31e-05	0.000362	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CD86—hematologic cancer	3.3e-05	0.000362	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	3.28e-05	0.00036	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HES1—hematologic cancer	3.26e-05	0.000357	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	3.24e-05	0.000355	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CD86—hematologic cancer	3.23e-05	0.000354	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	3.21e-05	0.000352	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	3.2e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	3.2e-05	0.000351	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HES1—hematologic cancer	3.19e-05	0.000349	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	3.17e-05	0.000347	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	3.16e-05	0.000346	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	3.15e-05	0.000346	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	3.15e-05	0.000345	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	3.13e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	3.13e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	3.12e-05	0.000342	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	3.1e-05	0.00034	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	3.09e-05	0.000339	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	3.09e-05	0.000339	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	3.09e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	3.09e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	3.08e-05	0.000338	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	3.05e-05	0.000334	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	3.03e-05	0.000332	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	3.02e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	3.02e-05	0.000331	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	2.89e-05	0.000316	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	2.87e-05	0.000314	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TERT—hematologic cancer	2.85e-05	0.000313	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	2.82e-05	0.000309	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	2.8e-05	0.000307	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TERT—hematologic cancer	2.79e-05	0.000306	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	2.79e-05	0.000305	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	2.73e-05	0.000298	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	2.72e-05	0.000298	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	2.66e-05	0.000292	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	2.62e-05	0.000287	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	2.59e-05	0.000284	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	2.56e-05	0.000281	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	2.54e-05	0.000279	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	2.54e-05	0.000278	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FN1—hematologic cancer	2.51e-05	0.000275	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	2.49e-05	0.000273	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BAD—hematologic cancer	2.48e-05	0.000272	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	2.48e-05	0.000272	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	2.46e-05	0.000269	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FN1—hematologic cancer	2.46e-05	0.000269	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BAD—hematologic cancer	2.43e-05	0.000266	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	2.43e-05	0.000266	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CD80—hematologic cancer	2.41e-05	0.000264	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	2.41e-05	0.000263	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	2.41e-05	0.000263	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KIT—hematologic cancer	2.41e-05	0.000263	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	2.41e-05	0.000263	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	2.36e-05	0.000259	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CD80—hematologic cancer	2.36e-05	0.000258	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	2.35e-05	0.000258	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KIT—hematologic cancer	2.35e-05	0.000258	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	2.35e-05	0.000258	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	2.31e-05	0.000253	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	2.3e-05	0.000252	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	2.29e-05	0.000251	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	2.26e-05	0.000248	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	2.25e-05	0.000247	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	2.24e-05	0.000245	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	2.24e-05	0.000245	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	2.23e-05	0.000245	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	2.23e-05	0.000244	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	2.21e-05	0.000242	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	2.19e-05	0.00024	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	2.18e-05	0.000239	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	2.18e-05	0.000239	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	2.13e-05	0.000233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	2.11e-05	0.000232	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.09e-05	0.000229	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	2.08e-05	0.000228	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	2.07e-05	0.000227	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	2.07e-05	0.000226	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.05e-05	0.000224	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	2.02e-05	0.000222	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	2.02e-05	0.000222	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	2e-05	0.000219	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	1.98e-05	0.000217	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	1.95e-05	0.000214	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	1.94e-05	0.000212	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	1.9e-05	0.000208	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	1.9e-05	0.000208	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	1.89e-05	0.000207	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	1.86e-05	0.000204	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	1.85e-05	0.000203	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	1.84e-05	0.000202	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	1.84e-05	0.000202	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	1.8e-05	0.000197	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	1.8e-05	0.000197	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	1.76e-05	0.000193	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	1.73e-05	0.000189	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	1.72e-05	0.000188	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	1.71e-05	0.000187	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	1.7e-05	0.000186	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL2—hematologic cancer	1.69e-05	0.000185	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	1.69e-05	0.000185	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	1.68e-05	0.000184	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	1.67e-05	0.000183	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	1.66e-05	0.000182	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL2—hematologic cancer	1.66e-05	0.000181	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	1.65e-05	0.000181	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	1.65e-05	0.00018	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JUN—hematologic cancer	1.65e-05	0.00018	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	1.61e-05	0.000177	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JUN—hematologic cancer	1.61e-05	0.000176	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	1.6e-05	0.000175	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	1.59e-05	0.000174	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	1.56e-05	0.000171	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	1.56e-05	0.000171	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	1.56e-05	0.000171	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	1.55e-05	0.00017	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	1.52e-05	0.000167	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	1.52e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EP300—hematologic cancer	1.52e-05	0.000166	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EP300—hematologic cancer	1.49e-05	0.000163	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SRC—hematologic cancer	1.48e-05	0.000162	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SRC—hematologic cancer	1.44e-05	0.000158	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	1.44e-05	0.000158	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	1.42e-05	0.000156	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	1.42e-05	0.000156	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	1.41e-05	0.000154	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	1.39e-05	0.000153	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.39e-05	0.000152	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	1.36e-05	0.000149	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	1.33e-05	0.000146	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MYC—hematologic cancer	1.32e-05	0.000145	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	1.32e-05	0.000145	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.29e-05	0.000142	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.29e-05	0.000141	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	1.22e-05	0.000134	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.2e-05	0.000131	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	1.12e-05	0.000123	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-05	0.00012	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TP53—hematologic cancer	1.09e-05	0.000119	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.06e-05	0.000116	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	1.04e-05	0.000114	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.02e-05	0.000111	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—hematologic cancer	9.95e-06	0.000109	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—hematologic cancer	9.73e-06	0.000107	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	9.18e-06	0.000101	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	8.98e-06	9.83e-05	CbGpPWpGaD
